Cancer Management App For iPad Is An All-in-One Resource

The Cancer Management Handbook app, created by UBM Medica LLC, brings a popular cancer resource for health professionals to the iPad.

Although it's designed for medical professionals, the app is accessible for anyone who wants a handy all-in-one cancer resource on an iPad.

Content of the App

The app features 13 sections, including 11 sections devoted to cancer subtypes. The remaining two sections are devoted to Palliative and Supportive Care, and Complications.

The subtype sections are:

  • Cancers of the head and neck region
  • Lung cancer
  • Breast cancer
  • Gastrointestinal cancers
  • Genitourinary malignancies
  • Gynecologic malignancies
  • Skin cancers
  • Sarcomas
  • Brain tumors
  • Other solid tumors
  • Hematologic malignancies

Here's a screenshot showing the Hematologic malignancies subtype section in which Hodgkin's lymphoma is highlighted on the left and the contents are on the right:

For a disease as complicated and confusing as cancer, this app makes navigating through it all easy.

The Only Complaint

There is one complaint I have with the app, although it's not big enough to get me to remove the app or not recommend it.

The complaint has to do with the top border, which currently displays a banner ad for Roche's Gazyva, an anti CD20 drug that the drug-maker would ideally like to see replace Rituxan as the monoclonal antibody of choice in patients with indolent non-Hodgkin's lymphoma.

I accept that it's a great benefit that the app is free and a primary reason it's free is because of this advertisement; I just oppose this kind of advertising by drug companies.

Where to Find this App

Click here to find the app online, or search "Cancer Management Handbook" at the Apple app store.

More Articles

More Articles

Amazon.com is pleased to have the Lymphoma Information Network in the family of Amazon.com associates. We've agreed to ship items...

The question ought to be what are myelodysplastic syndromes (MDS), since this is a group of similar blood and bone marrow diseases that...

Merkel Cell Carcinoma (MCC) is a very rare and aggressive skin cancer that usually develops when a person is in his or her 70s. It is...

Radiation Therapy Topics

...

At some point, the Seattle biotech company Cell Therapeutics Inc (CTI) should earn an entry in the Guinness Book of World Records for utter and...

Site Beginnings

This site was started as Lymphoma Resource Page(s) in 1994. The site was designed to collect lymphoma...

Three papers appearing in the journal Blood and pointing towards a regulator-suppressor pill could offer hope to blood cancer...

The US Food and Drug Administration (FDA) has granted a third so-called Breakthrough Therapy Designation for the investigational oral...

The US Food and Drug Administration today has approved an expanded use of Imbruvica (ibrutinib) in patients with...

The U.S. Food and Drug Administration has announced that it has granted "Breakthrough Therapy Designation" for the investigational agent...

According to a new study published in the Proceedings of the National Academy of Sciences, a team from the University of California, San...

Pharmacyclics has announced that the company has submitted a New Drug Application (NDA) to the US Food and Drug Administration (FDA) for...

New research suggests that frontline radioimmunotherapy...

Gilead Sciences has announced results of the company's Phase II study of its investigational compound idelalisib, an oral inhibitor of...

Sitemap